A general introduction to pharmaceutical IP and competition

This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in Portugal, with particular regard to recent developments.

Related Keywords

China , Porto , Portugal , United States , Lisbon , Lisboa , Portuguese , , Health Cluster , National Health System , Ministry Of Health , Champalimaud Centre , Portugal Global Business Development Agency , Portuguese Regulatory Medicines Agency Infarmed , Portuguese Pharmaceutical Industry Association Apifarma , Portuguese Competition Authority Ad , European Union , European Medicines Agency , Sunovion Pharmaceuticals Inc , Health Cluster Portugal The , Health Cluster Portugal , Drug Administration , Portuguese Regulatory Medicines Agency , Business Development Agency , Portuguese Pharmaceutical Industry Association , Strategic Project , Portuguese Pharmaceutical Industry , Portuguese Competition Authority , Medicines Act , National Health , Industrial Property Code , Competition Act , Private Enforcement , Law , Lawyers , Legal , Aw Firms , Aw Updates , Egal Updates , Egal Developments , Aw Developments , Egal Newsletters , Egal Current Awareness , Deals , Egal Advisers , Egal Advisors , Egal Directory , Ompetition Amp Antitrust ,